Atea Pharmaceuticals
AVIR
AVIR
127 hedge funds and large institutions have $323M invested in Atea Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
127
Holding in Top 10
1
Calls
$612K
Puts
–
Top Buyers
| 1 | +$10.4M | |
| 2 | +$5.38M | |
| 3 | +$5.14M | |
| 4 |
ICM
Irenic Capital Management
New York
|
+$1.39M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.28M |
Top Sellers
| 1 | -$1.98M | |
| 2 | -$1.87M | |
| 3 | -$1.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$853K |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$745K |
